Pelvic Organ Preservation in Non-muscle-invasive Bladder Cancer: Less Is More

被引:3
作者
Faulk, Anne [1 ]
Avulova, Svetlana [2 ]
Bree, Kelly K. [3 ]
Baak-Kukreja, Janet [4 ]
Westerman, Mary E. [5 ,6 ,7 ]
机构
[1] LSU Hlth Sci Ctr, Sch Med, New Orleans, LA USA
[2] Albany Med Ctr, Dept Urol, Albany, NY USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX USA
[4] Univ Colorado, Div Urol, Aurora, CO USA
[5] LSU Hlth Sci Ctr, Dept Urol, New Orleans, LA USA
[6] East Jefferson Gen Hosp, Dept Surg, Metairie, LA USA
[7] LSU Hlth Sci Ctr, Dept Urol, 1542 Tulane Ave, New Orleans, LA 70112 USA
来源
EUROPEAN UROLOGY FOCUS | 2023年 / 9卷 / 04期
关键词
Radical cystectomy; Ovary preservation; Sexual function; Quality of life; Oncological outcomes; Non-muscle-invasive bladder; cancer; OUTCOMES; WOMEN;
D O I
10.1016/j.euf.2023.04.006
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Radical cystectomy (RC) is a treatment option for high-risk non-muscle-invasive bladder cancer (NMIBC) but is associated with high morbidity and a negative impact on quality of life. Reproductive or pelvic organ-sparing cystectomy (ROSC) techniques have emerged as a potential strategy to mitigate some potential effects of standard RC. Here we discuss current knowledge regarding oncological, functional, and sexual function outcomes associated with ROSC and their applicability in NMIBC. These outcomes can be used to make informed clinical decisions regarding cystectomy technique in appropriately staged and selected patients with NMIBC. Patient summary: We reviewed results for bladder cancer control, urinary function, and sexual function after removal of the bladder with and without techniques to spare reproductive or pelvic organs. We found evidence of better sexual function outcomes with a sparing approach without compromise of cancer control. Further studies are needed to assess urinary function and pelvic floor-related outcomes. & COPY; 2023 European Association of Urology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:571 / 574
页数:4
相关论文
共 10 条
  • [1] Prevalence, Predictors, and Oncologic Outcomes of Pelvic Organ Involvement in Women Undergoing Radical Cystectomy
    Avulova, Svetlana
    Benidir, Tarik
    Cheville, John C.
    Packiam, Vignesh T.
    Shah, Paras
    Frank, Igor
    Tollefson, Matthew K.
    Thompson, Houston
    Karnes, R. Jeffrey
    Thapa, Prabin
    Kulkarni, Girish
    Boorjian, Stephen A.
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2023, 147 (02) : 202 - 207
  • [2] European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)
    Babjuk, Marko
    Burger, Maximilian
    Capoun, Otakar
    Cohen, Daniel
    Comperat, Eva M.
    Escrig, Jose L. Dominguez
    Gontero, Paolo
    Liedberg, Fredrik
    Masson-Lecomte, Alexandra
    Mostafid, A. Hugh
    Palou, Joan
    van Rhijn, Bas W. G.
    Roupret, Morgan
    Shariat, Shahrokh F.
    Seisen, Thomas
    Soukup, Viktor
    Sylvester, Richard J.
    [J]. EUROPEAN UROLOGY, 2022, 81 (01) : 75 - 94
  • [3] Female Sexual Function Following Radical Cystectomy in Bladder Cancer
    Davis, Laura
    Isali, Ilaha
    Prunty, Megan
    Calaway, Adam
    Mishra, Kirtishri
    Miller, April
    Pope, Rachel
    Magee, Diana
    Bigalli, Alberto Castro
    Thirumavalavan, Nannan
    Ponsky, Lee
    Bukavina, Laura
    [J]. SEXUAL MEDICINE REVIEWS, 2022, 10 (02) : 231 - 239
  • [4] Oncological and functional outcomes of sexual function-preserving cystectomy compared with standard radical cystectomy in men: A systematic review
    Hernandez, Virginia
    Linares Espinos, Estefania
    Dunn, James
    MacLennan, Steven
    Lam, Thomas
    Yuan, Yuhong
    Comperat, Eva
    Cowan, Nigel C.
    Gakis, Georgios
    Lebret, Thierry
    van der Heijden, Antoine G.
    Witjes, Johannes Alfred
    Ribal, Maria J.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (09) : 539.e17 - 539.e29
  • [5] Packiam VT, 2020, UROL ONCOL, V38
  • [6] Safety and Efficacy of Reproductive Organ-Sparing Radical Cystectomy in Women With Variant Histology and Advanced Stage
    Patel, Sunil H.
    Wang, Shirley
    Metcalf, Meredith R.
    Gupta, Natasha
    Gabrielson, Andrew
    Lee, Esther
    Rostom, Mary
    Pierorazio, Phil
    Smith, Armine
    Hahn, Noah
    Schoenberg, Mark
    Kates, Max
    Hoffman-Censits, Jean
    Bivalacqua, Trinity J.
    [J]. CLINICAL GENITOURINARY CANCER, 2022, 20 (01) : 60 - 68
  • [7] Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy
    Pettus, Joseph A.
    Al-Ahmadie, Hikmat
    Barocas, Daniel A.
    Koppie, Theresa M.
    Herr, Harry
    Donat, S. Machele
    Dalbagni, Guido
    Reuter, Victor E.
    Olgac, Semra
    Bochner, Bernard H.
    [J]. EUROPEAN UROLOGY, 2008, 53 (02) : 370 - 375
  • [8] Vaginal Complications after Cystectomy: Results from a Medicare Sample
    Richter, Lee A.
    Osazuwa-Peters, Oyomoare L.
    Routh, Jonathan C.
    Handa, Victoria L.
    [J]. JOURNAL OF UROLOGY, 2022, 207 (04) : 789 - 796
  • [9] Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
    Sung, Hyuna
    Ferlay, Jacques
    Siegel, Rebecca L.
    Laversanne, Mathieu
    Soerjomataram, Isabelle
    Jemal, Ahmedin
    Bray, Freddie
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2021, 71 (03) : 209 - 249
  • [10] Systematic review of the oncological and functional outcomes of pelvic organ-preserving radical cystectomy (RC) compared with standard RC in women who undergo curative surgery and orthotopic neobladder substitution for bladder cancer
    Veskimae, Erik
    Neuzillet, Yann
    Rouanne, Mathieu
    MacLennan, Steven
    Lam, Thomas B. L.
    Yuan, Yuhong
    Comperat, Eva
    Cowan, Nigel C.
    Gakis, Georgios
    van der Heijden, Antoine G.
    Ribal, Maria J.
    Witjes, Johannes Alfred
    Lebret, Thierry
    [J]. BJU INTERNATIONAL, 2017, 120 (01) : 12 - 24